Preliminary findings reveal T2*-mapping may effectively assess high-intensity focused ultrasound (HIFU) results in uterine myomas and adenomyosis.
Motivation: Evaluating treatment efficacy of high-intensity focused ultrasound (HIFU) is crucial for physicians to determine whether the procedure is complete. Goal(s): This preliminary study validates the use of T2*-mapping with iDEAL-IQ for evaluating the treatment effects of HIFU without contrast injection. Approach: A decrease in T2* values was observed in the lesion region between different oxygenation conditions, while equal or increased values were noted after treatment. Results: These preliminary results suggest that T2* mapping could be an effective tool for treatment assessment. Impact: T2*-mapping, which can reveal the variations in oxygenation, would be an effective tool for assessing treatment outcomes of high-intensity focused ultrasound (HIFU) in uterine myomas and adenomyosis, without the need for contrast injection.
No takes yet. Share an insight, caveat, or question.
Chuang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: